Pyridine scaffolds, phenols and derivatives of azo moiety: current therapeutic perspectives

T Tahir, M Ashfaq, M Saleem, M Rafiq, MI Shahzad… - Molecules, 2021 - mdpi.com
Synthetic heterocyclic compounds have incredible potential against different diseases;
pyridines, phenolic compounds and the derivatives of azo moiety have shown excellent …

Multitargeting compounds: a promising strategy to overcome multi-drug resistant tuberculosis

G Stelitano, JC Sammartino, LR Chiarelli - Molecules, 2020 - mdpi.com
Tuberculosis is still an urgent global health problem, mainly due to the spread of multi-drug
resistant M. tuberculosis strains, which lead to the need of new more efficient drugs. A …

Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors

O Ozten, BZ Kurt, F Sonmez, B Dogan, S Durdagi - Bioorganic Chemistry, 2021 - Elsevier
In the present study, new tacrine derivatives containing carbamate group were synthesized
and their acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition …

Nickel‐Catalyzed Synthesis of N‐(Hetero)aryl Carbamates from Cyanate Salts and Phenols Activated with Cyanuric Chloride

I Dindarloo Inaloo, M Esmaeilpour, S Majnooni… - …, 2020 - Wiley Online Library
A simple and efficient domino reaction has been designed and employed for the one‐pot
synthesis of N‐(hetero) aryl carbamates through the reaction between alcohols and in‐situ …

Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis, in vitro, kinetic and docking studies

T Tahir, MI Shahzad, R Tabassum, M Rafiq… - Journal of Enzyme …, 2021 - Taylor & Francis
In the present study, a series of azo derivatives (TR-1 to TR-9) have been synthesised via
the diazo-coupling approach between substituted aromatic amines with phenol or naphthol …

Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)

A Egorova, EG Salina, V Makarov - International Journal of Molecular …, 2021 - mdpi.com
Latent tuberculosis infection (LTBI) represents a major challenge to curing TB disease.
Current guidelines for LTBI management include only three older drugs and their …

Synthesis, Antimicrobial Activity, Molecular Docking and DFT Study: Aryl‐Carbamic Acid 1‐Benzyl‐1H‐[1,2,3]Triazol‐4‐ylmethyl Esters

Naveen, R Kumar Tittal, GD Vikas, P Rani… - …, 2020 - Wiley Online Library
Abstract Bioactive carbamate‐1, 4‐disubstituted 1, 2, 3‐triazole hybrid molecules were
synthesized and characterized in high yield from carbamate‐linked terminal alkynes and in …

Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides

LB Horváth, M Krátký, V Pflégr, E Méhes… - European Journal of …, 2022 - Elsevier
Mycobacterium tuberculosis is an intracellular pathogen and the uptake of the
antimycobacterial compounds by host cells is limited. Novel antimycobacterials effective …

[HTML][HTML] Substituted N-phenylitaconamides as inhibitors of mycobacteria and mycobacterial isocitrate lyase

M Krátký, E Novotná, J Stolaříková, M Švarcová… - European Journal of …, 2022 - Elsevier
Novel antimycobacterial drugs are needed, especially those with dual activity against both
actively growing and non-replicating subpopulations of mycobacteria. Isocitrate lyase (ICL) …

Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis

NH Le, P Constant, S Tranier, V Nahoum… - Bioorganic & Medicinal …, 2022 - Elsevier
Tuberculosis (TB) remains a global health crisis, further exacerbated by the slow pace of
new treatment options, and the emergence of extreme and total drug resistance to existing …